Join
Live feed
·
INSIDERFilingvia Quantisnow
Nautilus Biotechnology Inc. logo

SEC Form 4: Sankar Subramanian bought $30,399 worth of shares (15,000 units at $2.03), increasing direct ownership by 20% to 91,250 units

ByQuantisnow·Wall Street's wire, on your screen.
NAUT· Nautilus Biotechnology Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAUT (Nautilus Biotechnology Inc.) and more on Quantisnow.